US Earnings Financial Results SEC Filings — April 03, 2026

03-04-2026

Karman Holdings Inc. reported robust FY2025 revenue growth of 36.6% YoY to $471,500 thousand, fueled by strong performance across all segments including Tactical Missiles and Integrated Defense Systems up 48.5%, with backlog expanding to $801,056 thousand. However, operating margin contracted 2.9 percentage points to 15.5% amid a 92.8% surge in G&A expenses to $85,656 thousand, and cash from operating activities swung to a negative $(22,119) thousand from $26,645 thousand prior year. Net income rose 36.7% to $17,366 thousand, though net income margin remained flat at 3.7%.

• ·Adjusted EBITDA increased to $145,302 thousand in FY2025 from $106,144 thousand in FY2024, with margin slightly up to 30.8%.
• ·Total debt to total capitalization ratio improved to 1.52 from 2.25.
• ·Cash and cash equivalents rose to $33,959 thousand as of Dec 31, 2025 from $11,530 thousand.
• ·GAAP EPS was $0.13 in FY2025 vs $0.08 in FY2024; Adjusted EPS $0.37 vs $0.13.

03-04-2026

TCW Direct Lending LLC's total investment income declined 44% YoY to $17,476 for the year ended December 31, 2025 from $31,478 in 2024, driven by sharp drops in interest income (-28%) and paid-in-kind interest (-68%), while net investment income fell 62% to $6,172. Net realized losses widened to $(32,894) from $(9,398); however, unrealized appreciation improved significantly to $5,325 from $(105,977) depreciation, leading to a smaller net decrease in Members’ Capital from operations of $(17,300) versus $(93,456). Net expenses decreased 26% to $11,304 amid lower interest and management fees.

• ·Top 2025 unrealized gain: Animal Supply Company, LLC Term Loan $26,676
• ·Largest 2025 unrealized loss: Pace Industries, Inc. Term Loan $(18,460)
• ·Credit facility average outstanding balance declined to $63,038 in 2025 from $81,582 in 2024
• ·Unfunded commitments rose to $21,737 at Dec 31, 2025, primarily from Overton Chicago Gear, LLC Revolver $16,816

03-04-2026

For the year ended December 31, 2025, POWERDYNE INTERNATIONAL, INC. reported revenues of $1,160,976, down 7.2% YoY from $1,251,454, while gross profit improved 3.5% to $378,427; however, operating expenses rose 15.5% to $629,837, leading to a widened net loss of $251,410 from $179,579 in 2024. Cash balance ended slightly higher at $47,382 versus $45,579, supported by $193,808 in financing activities, though net cash used in operations was $192,005. Total assets grew to $341,923 from $219,330, but liabilities increased to $846,877 and stockholders' deficit deepened to $504,954.

• ·Trade accounts receivable decreased to $76,018 from $87,456.
• ·Inventories increased to $94,555 from $74,488.
• ·Line of credit balance rose to $219,750 from $165,500.
• ·Cash paid for interest increased to $20,744 from $4,326.

03-04-2026

Ooma Inc reported FY2026 total revenue of $273,602 up 7% YoY from $256,852, with subscription and services revenue growing 6% to $252,015 and product revenue up 19% to $21,587, while core users increased to 1,404 from 1,234 and AERR rose to $245,908 from $234,086. Adjusted EBITDA improved significantly to $33,947 from $23,257, and GAAP net income turned positive at $6,459 versus a $6,901 loss; however, total operating expenses remained essentially flat at $162,984, R&D expenses declined 7% to $50,259, G&A rose 10% to $34,384, and product gross margin was negative at -44% despite improvement from -63%.

• ·Total gross margin flat at 61% YoY.
• ·Subscription and services gross margin stable at 70%.
• ·Stock-based compensation expense decreased to $15,217 from $18,217.

03-04-2026

GOOD GAMING, INC. narrowed its net loss to $235,674 in 2025 from $962,963 in 2024, a 75.5% reduction driven by operating expenses dropping 75.6% to $231,854 from $949,434, primarily due to lower professional fees and general/administrative costs. However, revenues fell to $0 from $433, total liabilities rose 22.6% to $1,198,806 amid higher related-party payables, and stockholders' deficit widened to $(1,107,691) from $(885,682). Total assets remained flat at approximately $91,000 with cash slightly down to $13,477.

• ·Professional fees declined to $94,747 in 2025 from $498,035 in 2024.
• ·General and administrative expenses reduced to $137,107 in 2025 from $258,856 in 2024.
• ·Net cash used in operating activities improved to $(1,022) in 2025 from $(281,216) in 2024.
• ·Intangible assets netted to $0 as of Dec 31, 2025 after full impairment in prior year.
• ·Auditor has served since 2022 (PCAOB ID: 6771).

03-04-2026

Concentrix Corp reported revenue of $2,500,391 thousand for the three months ended February 28, 2026, up 5.4% YoY from $2,372,222 thousand, driven by growth in operations. However, gross profit declined slightly by 0.7% to $849,657 thousand, operating income fell 30% YoY to $118,559 thousand due to higher SG&A expenses, and net income dropped sharply 69% to $21,589 thousand with diluted EPS of $0.33 versus $1.04. Operating cash flow swung to a use of $83,220 thousand from a provision of $1,408 thousand YoY, while total assets decreased to $10,674,622 thousand from $10,761,086 thousand QoQ.

• ·Company repurchased 1,081 shares of common stock for $43,194 thousand and paid dividends of $23,149 thousand during the quarter.
• ·Refinanced debt by issuing $599,796 thousand Senior Notes due 2029 and repaying $600,000 thousand Senior Notes due 2026.
• ·Accounts receivable, net increased QoQ to $2,038,296 thousand from $1,999,021 thousand.
• ·Assets held for sale of $207,502 thousand and related liabilities of $174,941 thousand as of February 28, 2026, with a $5,929 thousand loss recognized.

03-04-2026

Elventix Technology Corp reported zero revenues and net losses of $31,820 for the three months ended February 28, 2026 and $68,189 for the nine months ended, with loss per share steady at $0.01 amid higher weighted average shares outstanding. While the company raised $38,925 via issuance of 1,297,500 common shares at $0.03 each and total assets grew 7.5% to $231,194, cash declined 64.4% to $890, stockholders' equity swung to a $(24,963) deficit from $4,301, and liabilities rose 21.5% to $256,157. Operating cash flows used $68,707, reflecting ongoing expenses including amortization of $34,214 and R&D of $5,500.

• ·Operating expenses totaled $31,820 for three months (including amortization $12,027, server rental $8,400, R&D $5,500) and $36,369 for nine months.
• ·Promissory note payable: $163,000 (down from $188,538); related party loan payable: $92,709 (up from $22,199).
• ·Accumulated deficit: $(68,388) as of February 28, 2026.
• ·No cash paid for interest or income taxes.

03-04-2026

Sunshine Biopharma Inc. (SBFMW) reported total assets of $30,079,167 as of December 31, 2025, down 1.6% from $30,560,392 in 2024, with cash and cash equivalents declining 5.8% to $9,123,308 while inventory increased 19.5% to $13,472,025. Total current assets rose 3.4% to $26,853,581, but shareholders' equity fell 2.0% to $23,038,460 amid a widened accumulated deficit to $75,015,126 from $69,039,774. The filing highlights risks to Nora Pharma's generic drug business, including supply chain disruptions from geopolitical tensions and pricing pressures.

• ·Common shares outstanding increased to 4,905,945 from 2,580,098, indicating significant dilution.
• ·Intangible assets declined to $1,889,370 from $3,019,717.
• ·Nora Pharma's generics manufactured outside Canada/US, vulnerable to supply chain disruptions from wars in Ukraine/Middle East.
• ·Risks include price erosion on existing products, delays in new product launches, and changes in Canadian reimbursement frameworks.

03-04-2026

For the year ended December 31, 2025, TCW Direct Lending VII LLC reported total investment income of $89,233, a 35.1% decline from $137,519 in 2024, and net investment income of $87,116, down 38.7% from $142,235. While net expenses improved to $2,117 from a negative $(4,716) and unrealized depreciation lessened to $(25,947) from $(76,496), a larger net realized loss of $(101,643) versus $(18,725) led to a net decrease in Members’ Capital of $(36,744) compared to an increase of $48,991 in 2024. Interest and credit facility expenses decreased to $17,913 from $23,451, reflecting lower average outstanding balance.

• ·Unfunded commitments increased to $12,516 as of Dec 31, 2025 from $9,750 as of Dec 31, 2024.
• ·Weighted average interest rate on credit facilities declined to 6.36% in 2025 from 7.75% in 2024.
• ·Incentive fees showed a reversal to $(35,680) in 2025 from $(47,062) in 2024.
• ·Largest unrealized depreciation changes in 2025 included $(20,534) for RL Parent Holdings LLC Class A Units and $12,068 appreciation for Mondee Holdings LLC Term Loan.

03-04-2026

RCM Technologies reported FY ended January 3, 2026 revenue of $319,404 (up 14.7% YoY from $278,380), driven by Specialty Health Care (+15.0% to $164,104) and Engineering (+24.9% to $120,486), but Life Sciences, Data and Solutions declined 11.3% YoY to $34,814. Gross profit increased 10.2% to $87,943 though margin compressed to 27.5% from 28.7%, operating income rose 12.4% to $25,093, and net income grew 22.6% to $16,334; the company repurchased 114,942 shares at a weighted average price of $19.48 with $34,886,000 remaining under the program.

• ·Adjusted EBITDA increased to $30,743 from $25,855 YoY.
• ·Cash used in financing activities was $19,038 (vs. $4,828 prior year), primarily due to share repurchases.
• ·Weighted average price paid per share repurchased: $19.48.

03-04-2026

Totaligent, Inc. reported a drastic revenue decline to $2,248 in 2025 from $444,529 in 2024, a 99.5% drop, contributing to a net loss of $600,046, which narrowed from $947,236 the prior year. Cash and cash equivalents fell sharply to $4,689 at year-end from $22,128, amid higher operating cash burn of $(265,041) versus $(212,495), while total liabilities rose to $2,370,734 from $1,960,177. The company detailed an acquisitions strategy targeting AI companies, digital marketing platforms, and Zcash cryptocurrency mining to fuel growth.

• ·Public float less than $700 million with annual revenues under $100 million.
• ·Gross profit $2,248 in 2025 (down from $43,068 in 2024).
• ·Stockholders' deficit widened to $(2,164,267) from $(1,737,252).
• ·Proceeds from convertible notes payable: $230,000 in 2025.

03-04-2026

Token Communities Ltd. (TKCM) reported total revenues of $356,579 for the year ended June 30, 2025, an 85% YoY decline from $2,428,672, driven by home sales dropping 87% to $315,000, leading to a net loss of $464,107 versus net income of $1,276,464 in 2024 and gross margin shrinking 98% to $18,499. Total assets grew 51% to $6,037,968, supported by inventory up 47% to $5,818,102 and new construction in progress of $157,025, while cash ended at $62,841, up 142% from $25,939. However, liabilities rose 29% to $11,241,899 including a new $3,170,549 construction loan, widening stockholders' deficit to $5,203,931 from $4,740,500.

• ·Shares outstanding: 2,095,671,162 both periods.
• ·Net cash used in investing activities: $(157,025) FY2025 vs $0 FY2024.
• ·Acquisition of ASC Global Inc in FY2024 involved $5,000,000 notes payable and net assets of $320,010.
• ·Audit procedures focused on construction costs including testing disbursements and vendor confirmations.